Appointments: 215-464-3300 | Hours: Mon–Fri: 8am–8pm
  • For Patients
    • For Patients
    • Test Preparation
    • Frequently Asked Questions
    • Insurances Accepted
    • Insurance & Payment Questions
    • Worker’s Compensation and Motor Vehicle Accident Insurance
    • Scheduling an Appointment
    • Radiology Information System
  • For Doctors
    • For Doctors
    • Insurances Accepted
    • Access to Patient Records
  • Test Preparation
  • Pay Bill
  • Self Pay
  • Jobs

Independent Physicians Medical CenterIndependent Physicians Medical Center

  • Radiology
    • MRI
      • MRI
      • MRA
      • MRCP
      • MRI and MRA Contrast
      • MRI Preparation
    • CT Scan
      • CT Scan
      • CTA
      • Types of CT Scan
      • CT Scan Preparation
    • Nuclear Medicine
      • Nuclear Medicine
      • Types of Nuclear Tests
      • Nuclear Test Preparation
    • Ultrasound
      • Ultrasound
      • Types of Ultrasounds
      • Ultrasound Preparation
    • X-Ray
      • X-Ray
      • X-Ray Preparation
    • Mammography
      • Mammography
      • 3D Mammography
      • Mammography Preparation
    • DEXA Scan
      • DEXA Scan
      • DEXA Scan Preparation
  • Cardiology
    • Cardiology
    • Stress Test
    • Echocardiography
    • Stress Echo
    • Coronary CTA
    • Cardiology Preparation
    • Our Cardiologists
  • Specialists
    • Orthopedics
    • Podiatrics
    • Sleep Study
    • Vascular System
  • Oncology
  • News
    • Company News
    • Health Information
    • Forms Download
    • Newsletter
  • Contact Us

New Research Shows Promise for Possible HIV Cure

by vladi / Monday, 31 March 2014 / Published in Health Information, News and Resources

Researchers have used radioimmunotherapy (RIT) to destroy remaining HIV-infected cells in the blood samples of patients treated with antiretroviral therapy. The approach could provide a strategy for curing HIV infection, according to research presented at RSNA 2013.

Highly active antiretroviral therapy (HAART) has transformed the outlook for patients infected with HIV by suppressing the replication of the virus in the body. How- ever, despite its success, scientists believe reservoirs of latently infected cells persist in the body, preventing the possibility of a permanent cure.

“In an HIV patient on HAART, drugs suppress viral replication, which means they keep the number of viral particles in a patient’s bloodstream very low. However, HAART cannot kill the HIV-infected cells,” said the study’s lead author, Ekaterina Dadachova, PhD, a professor of radiology, microbiology, and immunology at Albert Einstein College of Medicine in New York City. “Any strategy for curing HIV infection must include a method to eliminate viral-infected cells.”

In her study, Dadachova and a team of researchers administered RIT to blood samples from 15 HIV patients treated with HAART at the Einstein-Montefiore Center for AIDS Research.

RIT, which historically has been employed to treat cancer, uses monoclonal antibodies, or cloned cells that are recruited by the immune system to identify and neutralize antigens. The antibody, designed to recognize and bind to a specific cell antigen, is paired with a radioactive isotope. When injected into the patient’s bloodstream, the laboratory-developed antibody travels to the target cell where the radiation is then delivered. “In RIT, the antibodies bind to the infected cells and kill them by radiation,” Dadachova said. “When HAART and RIT are used together, they kill the virus and the infected cells, respectively.”

For the study, Dadachova’s team paired the monoclonal antibody (mAb2556) designed to target a protein expressed on the surface of HIV-infected cells with the radionuclide bismuth-213.

The researchers found that RIT could kill HIV-infected lymphocytes previously treated with HAART, reducing the HIV infection in the blood samples to undetectable levels. “The elimination of HIV-infected cells with RIT was profound and specific,” Dadachova said. “The radio- nuclide we used delivered radiation only to HIV-infected cells without damaging nearby cells.”

Dadachova said clinical trials in HIV patients are the next step in evaluating the treatment.

 

Source: Radiology Today

Tagged under: Einstein-Montefiore Center for AIDS Research, HAART, Highly active antiretroviral therapy, HIV cure, radioimmunotherapy, RIT, RSNA

What you can read next

Siemens Aspen Acuson
Ultrasound Measures Risk of Pulmonary Edema from Preeclampsia
Breast Imagers Assess MBI’s Role in Cancer Detection
MRI Shows Long-Term Impact of Veterans’ Blast-Induced Brain Injuries

Categories

  • Company News
  • Health Information
  • News and Resources

Search

Recent Stories

  • A Patient’s Guide to Open MRI

  • New Breast Imaging with 3D Tomosynthesis Solution at IPMC

  • Benefits of Stress Test

  • Orthopedic Treatments at IPMC

  • Podiatric Medicine at IPMC

Departments

  • Radiology
  • Cardiology
  • Specialists

Studies

  • MRI
  • CT Scan
  • Nuclear Medicine
  • Ultrasound
  • X-Ray
  • Mammography
  • DEXA Scan

Send Us a Message

Contact

9908 E. Roosevelt Blvd.
Philadelphia, PA 19115

215-464-3300 | Radiology

© IPMC 2020. All rights reserved.
Website by Baseline Works.

TOP
Coronavirus (COVID-19) - Latest Information for Patients and Visitors.
Learn more
This is default text for notification bar
Learn more